ロード中...
Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
The importance of the kidney’s role in glucose homeostasis has gained wider understanding in recent years. Consequently, the development of a new pharmacological class of anti-diabetes agents targeting the kidney has provided new treatment options for the management of type 2 diabetes mellitus (T2DM...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2014
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4166348/ https://ncbi.nlm.nih.gov/pubmed/25246775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S50773 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|